Company profile: PQ Bypass
1.1 - Company Overview
Company description
- Provider of minimally-invasive endovascular solutions advancing the treatment of long-segment peripheral artery disease.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PQ Bypass
Luminetx
HQ: United States
Website
- Description: Provider of bioscience technologies, including the VeinViewer Imaging System that images vascular structures, allowing healthcare professionals to clearly see accessible vasculature in real time on the skin surface.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Luminetx company profile →
Silver Creek Pharmaceuticals
HQ: United States
Website
- Description: Provider of protein therapeutics for cardiovascular disease and tissue repair, leveraging Smart Growth Factor technology to create growth factor fusion proteins for damaged tissues. Pipeline includes scp776, a targeted fusion protein in Phase II for acute ischemic stroke with preclinical efficacy in stroke, heart attack, and kidney injury, evaluated in the ARPEGGIO Phase II study for safety and neuroprotection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Silver Creek Pharmaceuticals company profile →
Alleviant Medical
HQ: United States
Website
- Description: Provider of transcatheter technology to lift the clinical and economic burden of heart failure, offering the Alleviant System to treat chronic heart failure by creating a connection between the heart's atrial chambers without leaving a permanent implant, and conducting the ALLAY-HF pivotal trial plus clinical evidence programs evaluating safety, effectiveness, and patient outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alleviant Medical company profile →
Supira Medical
HQ: United States
Website
- Description: Provider of catheter-based circulatory support devices for heart conditions, including the Supira System, a percutaneous ventricular assist device for high-risk percutaneous coronary interventions and cardiogenic shock, featuring a low profile, high continuous flow, and sensors for real-time pressure measurements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Supira Medical company profile →
Longeveron
HQ: United States
Website
- Description: Provider of cellular therapies and research programs, developing Lomecel-B, a culture-expanded medicinal signaling cell (MSC) therapy for aging-related diseases, Alzheimer’s disease, and hypoplastic left heart syndrome (HLHS), with programs testing its use in aging frailty, metabolic syndrome, and acute respiratory distress syndrome (ARDS) due to COVID-19 or influenza.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Longeveron company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PQ Bypass
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PQ Bypass
2.2 - Growth funds investing in similar companies to PQ Bypass
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PQ Bypass
4.2 - Public trading comparable groups for PQ Bypass
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →